Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Somatostatin, Hardback Book

Somatostatin Hardback

Edited by Coimbatore B. Srikant

Part of the Endocrine Updates series

Hardback

Description

Thirty years have passed since somatostatin was discovered and its hormonal function defined [1,2].

The wide range of anatomical distribution and actions of somatostatin and its receptors stimulated intense scientific and clinical interest, and fostered extensive research into all aspects of its biology including regulation of its gene expression, processing of its precursor, biological and cellular actions relating to regulation cell secretion, motility and proliferation.

The development of metabolically stable peptide analogs helped define its usefulness in the treatment of endocrine diseases and cancer.

The heterogeneity of somatostatin receptors recognized in 1981 [3] was later shown to result from the existence and variable expression of five distinct subtypes that constitutes two distinct subfamilies with distinguishing pharmacological characteristics [4,5].

The molecular cloning of these receptor subtypes reignited the interest in this field leading to a major increase in our insight into the biology of somatostatin and its receptor subtypes, and has led to the design and development of subtype-selective peptide and non-peptide agonists and antagonists.

Significant progress has been made in both basic and clinical research on somatostatin.

Noteworthy developments include the role of somatostatin in neuronal patterning, delineation of subtype-selective cytostatic / cytotoxic antiproliferative actions, manipulation of cellular signaling by oligomeric association of somatostatin receptor subtypes amongst themselves or with other G protein-coupled receptors, application of radionuclide-tagged derivatives to localize somatostatin receptor positive tumors and their treatment through targeted delivery of radionuclide or chemotoxin tagged agonists through receptor-mediated endocytosis.

Information

  • Format:Hardback
  • Pages:311 pages, 3 Illustrations, color; 28 Illustrations, black and white; XVI, 311 p. 31 illus., 3 illus
  • Publisher:Springer-Verlag New York Inc.
  • Publication Date:
  • Category:
  • ISBN:9781402077999
Save 18%

£89.99

£73.75

Item not Available
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

  • Format:Hardback
  • Pages:311 pages, 3 Illustrations, color; 28 Illustrations, black and white; XVI, 311 p. 31 illus., 3 illus
  • Publisher:Springer-Verlag New York Inc.
  • Publication Date:
  • Category:
  • ISBN:9781402077999

Also in the Endocrine Updates series  |  View all